토글닫기
팝업닫기

Refusal of Unauthorized Collection of E-mail Addresses

We do not allow the unauthorized collection of e-mail addresses listed on our website. Persons engaging in unauthorized collection with e-mail address collection programs or other technical devices will be subject to criminal prosecution in accordance with the Act on Information & Communications Network Utilization and Information Protection.

Contact Us

form mail list
Name *
Tel * - -
E-mail * @
Subject *
Contents
File1
File2
Spam Check* 자동등록방지번호
* 왼쪽의 자동등록방지 코드를 입력하세요.

Consent to Collect and Use Personal Information

I agree to the terms and conditions.

Platform Technology

RNAi platform development

Lead compound discovery

Pulmonology / Neurology

Pharmacological research on OliX RNAi compounds for respiratory and neurological diseases

Ophthalmology

Pharmacological research on OliX RNAi compounds for ocular diseases

Animal Research

Testing efficacy of oligonucleotide therapeutics using animal models

Analytics

Develop analytical methods for therapeutic candidates to determine purity and stability in support of nonclinical and clinical studies

PK/TK

Develop bioanalytical methods to quantitate therapeutic candidates in biological matrices for pharmacokinetic and toxicokinetic (PK/TK) studies

CMC

Manage manufacturing, analytics and quality of therapeutic candidates

Toxicology

Conduct safety evaluation and toxicokinetic assessment of therapeutic candidates through nonclinical studies

Clinical

Establish clinical development plans for therapeutic candidates and conduct clinical studies

Management

Business Management

Purchasing

General Affairs

Facility Management

Contingency Planning

Planning

Budget/Performance Management

Mid to Long-term Business Goals/Strategy Planning

Accounting & Finance

Make official announcements about business contents, financial condition, business performance etc.

Stabilize Internal Accounting Control System

IT

IT Infrastructure Management

IT Helpdesk

Human Resources

HR Policy/System Establishment, Organization/Job Design

Recruitment/HR Management

Performance Management, Employee Welfare

HR Development

Legal Affairs

Prevent, respond, handle legal disputes

Provide risk management and compliance support

Develop IP strategies for core technologies

Quality Assurance(QA)

Verify pharmaceutical R&D processes and results

Ensure product to meet the established quality standards

Business Development

Develop/Maintain Client Relationships

Execute Licensing Agreements

New Business/Strategy Planning

Communications

Provide investment information in a timely manner to increase company value

Promote management activities and establish internal/external communication strategies

Create positive corporate culture through various in-house activities and employee education

  • Home
  • PR

PR

News

News

게시물 목록
No. Title Date View
43
OliX to Conduct Business Meetings with Potential Partners at 2022 BIO International Convention

OliX to Conduct Business Meetings with Potential Partners at 2022 BIO International Convention

  • 2022-06-13
  • 조회수 : 120
 2022-06-13 120
42
OliX Announces Completion of Enrollment in Phase 2 Clinical Trial of OLX101A in Patients with Hypert

OliX Announces Completion of Enrollment in Phase 2 Clinical Trial of OLX101A in Patients with Hypert

  • 2022-06-07
  • 조회수 : 208
 2022-06-07 208
41
OliX Announces Completion of USD 45 Million Capital Raise for R&D and Financial Structure Improvemen

OliX Announces Completion of USD 45 Million Capital Raise for R&D and Financial Structure Improvemen

  • 2022-05-27
  • 조회수 : 648
 2022-05-27 648
40
OliX Identifies Effective Inhibition of Target Gene expression and Delivery of Candidate to Brain

OliX Identifies Effective Inhibition of Target Gene expression and Delivery of Candidate to Brain

  • 2022-05-27
  • 조회수 : 237
 2022-05-27 237
39
OliX Identifies Inhibition of Target Gene expression in Nonhuman Primate Models for NASH Candidate

OliX Identifies Inhibition of Target Gene expression in Nonhuman Primate Models for NASH Candidate

  • 2022-04-12
  • 조회수 : 489
 2022-04-12 489
38
OliX Pharmaceuticals to Participate in BIO-Europe Spring®

OliX Pharmaceuticals to Participate in BIO-Europe Spring®

  • 2022-03-24
  • 조회수 : 559
 2022-03-24 559
37
OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress

OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress

  • 2022-03-22
  • 조회수 : 545
 2022-03-22 545
36
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference

OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference

  • 2022-03-22
  • 조회수 : 432
 2022-03-22 432
35
OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences

OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences

  • 2022-03-22
  • 조회수 : 362
 2022-03-22 362
34
OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board

OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board

  • 2022-03-22
  • 조회수 : 325
 2022-03-22 325
33
OliX Pharmaceuticals to Conduct One-on-One Meetings at BIO-Europe Digital 2021 Conference

OliX Pharmaceuticals to Conduct One-on-One Meetings at BIO-Europe Digital 2021 Conference

  • 2022-03-22
  • 조회수 : 315
 2022-03-22 315
32
OliX Pharmaceuticals Enters Agreement with Pharmaron

OliX Pharmaceuticals Enters Agreement with Pharmaron

  • 2022-03-22
  • 조회수 : 367
 2022-03-22 367
31
Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration Agreement

Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration Agreement

  • 2021-10-19
  • 조회수 : 1774
 2021-10-19 1774
30
OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for OLX104C

OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for OLX104C

  • 2021-08-17
  • 조회수 : 2507
 2021-08-17 2507
29
OliX Pharmaceuticals Announces Results from Preclinical Study of NASH Therapeutic Candidate

OliX Pharmaceuticals Announces Results from Preclinical Study of NASH Therapeutic Candidate

  • 2021-08-05
  • 조회수 : 2117
 2021-08-05 2117
28
OliX Signs Agreement with LGC Biosearch Technologies for the Treatment of Androgenic Alopecia

OliX Signs Agreement with LGC Biosearch Technologies for the Treatment of Androgenic Alopecia

  • 2021-06-14
  • 조회수 : 1517
 2021-06-14 1517
27
OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA

OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA

  • 2021-06-14
  • 조회수 : 1517
 2021-06-14 1517
26
OliX Receives Notice of Allowance from US Patent and Trademark Office for Improved Technology

OliX Receives Notice of Allowance from US Patent and Trademark Office for Improved Technology

  • 2021-05-26
  • 조회수 : 1684
 2021-05-26 1684
25
OliX and PCI Biotech Announce a Collaboration to Combine Technologies

OliX and PCI Biotech Announce a Collaboration to Combine Technologies

  • 2021-05-11
  • 조회수 : 1498
 2021-05-11 1498
24
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

  • 2021-02-15
  • 조회수 : 2130
 2021-02-15 2130